Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / American Depository Shares
-
Shares outstanding
-
1,786,081
-
Total 13F shares
-
391,517
-
Share change
-
-128
-
Total reported value
-
$89,517
-
Price per share
-
$0.23
-
Number of holders
-
11
-
Value change
-
-$9,564
-
Number of buys
-
5
-
Number of sells
-
4
Institutional Holders of KAZIA THERAPEUTICS LTD - American Depository Shares (KZIA) as of Q2 2024
As of 30 Jun 2024,
KAZIA THERAPEUTICS LTD - American Depository Shares (KZIA) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
391,517 shares.
The largest 10 holders included
MORGAN STANLEY, BNP PARIBAS FINANCIAL MARKETS, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Virtu Financial LLC, UBS Group AG, RHUMBLINE ADVISERS, CITADEL ADVISORS LLC, WELLS FARGO & COMPANY/MN, Allworth Financial LP, and AdvisorNet Financial, Inc.
This page lists
11
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.